Livial

Product Overview

Livial is a prescription medication containing Tibolone as its active ingredient. Presented in tablet form, each dose delivers 2.5mg of this synthetic steroid hormone that exhibits estrogenic, progestogenic, and androgenic properties. Clinically prescribed for menopausal symptom management and osteoporosis prevention in postmenopausal women, Livial effectively restores hormonal equilibrium to alleviate common menopausal discomforts including hot flashes, nocturnal sweating, vaginal dryness, and related symptoms.

Therapeutic Applications

This medication is principally indicated for:
– Mitigation of menopausal symptoms (hot flashes, night sweats, vaginal atrophy, emotional lability)
– Osteoporosis prophylaxis in postmenopausal patients
– Enhancement of sexual function and quality of life during menopausal transition

Administration Guidelines

For optimal results:
1. Consume orally with 240ml (8oz) of water
2. Maintain consistent daily dosing schedule
3. Swallow tablets whole – do not crush or chew
4. Adhere strictly to prescribed regimen
5. Consult healthcare provider regarding missed doses

Mechanism of Action

Tibolone undergoes metabolic conversion into three bioactive metabolites that collectively:
– Modulate estrogen receptor activity
– Exhibit tissue-specific hormonal effects
– Maintain bone mineral density
– Restore genitourinary health
These actions collectively replicate premenopausal endocrine function while addressing climacteric symptoms.

Dosage Protocol

Standard therapeutic regimen:
– 2.5mg once daily (single tablet)
– Initiate at onset of confirmed menopause
– Duration determined by therapeutic response
– Regular medical evaluation recommended
– Dose adjustments require professional supervision

Therapeutic Advantages

• Comprehensive menopausal symptom relief
• Bone density preservation
• Improved urogenital health
• Enhanced psychological wellbeing
• Simplified once-daily dosing

Potential Adverse Effects

Common transient reactions may include:
– Mammary gland sensitivity
– Breakthrough uterine bleeding
– Cephalalgia
– Gastrointestinal discomfort
– Affective disturbances
Typically self-limiting; persistent symptoms warrant medical consultation.

Important Precautions

Contraindicated in patients with:
– Estrogen-dependent neoplasia history
– Thromboembolic disorders
– Significant hepatic impairment
Requires careful risk-benefit assessment in:
– Cardiovascular disease predisposition
– Metabolic disorders
– Concomitant medication use

Storage Requirements

Optimal preservation conditions:
– Ambient temperature (15-30°C)
– Protection from humidity
– Original packaging retention
– Secure storage away from pediatric access
– Strict adherence to expiration dating

Medical Disclaimer

This informational content is professionally curated to provide accurate, evidence-based knowledge. It is not intended to:
– Replace professional medical advice
– Constitute treatment recommendations
– Encompass all potential drug interactions
Patients should always consult qualified healthcare providers regarding therapeutic decisions. This material aims to facilitate informed patient-physician dialogue rather than substitute clinical judgment.